cell swelling; brain edema; anion channels; calcium dependence; 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid-acetoxymethyl ester; trifluoperazine; intracellular calcium concentration AS IN MOST CELL TYPES, cultured astrocytes exposed to hyposmotic medium undergo swelling and then regulate their volume back toward normal due to activation of K ϩ and Cl Ϫ efflux through volume-sensitive ion channels (3, 39) . Some free amino acids, especially taurine, may also participate in cell volume regulation in astrocytes (19, 38, 40) , as in other cell types (12) . Taurine-deficient astrocytes have higher volumes than control cells and show incomplete volume restoration in hyposmotic medium (30) . In neural cells in vivo and in vitro, taurine efflux is more sensitive to volume changes compared with other organic anions and K ϩ (37, 38, 57) .
These findings support the view that taurine may play a role as a major cell osmoregulatory molecule in the brain.
Taurine and other amino acids may have a special importance in volume regulation when cell swelling is promoted by increases in extracellular K ϩ , since net efflux of K ϩ and Cl Ϫ is likely to be suppressed under this condition. The high-K ϩ -induced release of taurine and other amino acids from cultured astrocytes is mediated primarily by volume-sensitive anion channels (20, 41, 45) . The molecular nature of these channels is currently being investigated (for review, see Refs. 35 and 51) . There is very limited work on the intracellular mechanisms linking the change in cell volume with the activation of transport pathways. In the case of hyposmotic swelling, Ca 2ϩ has been considered as a candidate for a volume signaling molecule in astrocytes (2, 32) , as in many other cell types (26) . The Ca 2ϩ dependence of high-K ϩ -induced taurine release in astrocytes is controversial. Both dependence (43) and independence (24, 41) have been reported. In comparisons of hyposmotic and high-K ϩ -induced astrocytic swelling and volume regulation, it should be noted that, depending on magnitude and rate of volume changes, different regulatory transport pathways and signaling mechanisms may be expected (50) . An additional important point is that treatments that inhibit high-K ϩ -induced amino acid release may affect entry of KCl to cause cell swelling in addition to, or instead of, inhibition of volume-dependent efflux, which will also cause inhibition of amino acid release. For hyposmotic-induced swelling, inhibition of the initial volume changes occurring from water influx is deemed much less likely. To help resolve some of these problems, we studied in the present work how treatments that differentially affect intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) alter both high-K ϩ medium-and hyposmotic medium-induced cell volume alterations and associated [ 3 H]taurine release in cultured astrocytes.
MATERIALS AND METHODS

Materials.
[ 3 H]taurine (specific activity 228 mCi/mg) and Na 2 51 CrO 4 (specific activity 571 mCi/mg) were obtained from Amersham (Arlington Heights, IL) and DuPont NEN Research Products (Boston, MA), respectively. Dispase (neutral protease dispase grade II) was purchased from Boehringer Mannheim (Indianapolis, IN). All cell culture reagents were from GIBCO (Grand Island, NY). Fura 2-AM was purchased from Molecular Probes (Eugene, OR). Flurphenazine-N-2-chloroethane dihydrochloride was from Calbiochem (San Diego, CA). Trifluoperazine, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-AM, and other chemicals, unless otherwise specified, were from Sigma Chemical (St. Louis, MI).
Cell cultures. Primary astrocyte cultures were prepared from the cerebral cortex of newborn Sprague-Dawley rats, as described by Frangakis and Kimelberg (8) . The dissociated cells were seeded on poly-D-lysine-coated 18 ϫ 18-mm coverslips (Bellco Biotechnology, Vineland, NJ), and cultures were used after 3-4 wk when the cells reached confluence. Immunocytochemistry showed that Ͼ95% of the cells stained positively for the astrocytic marker glial fibrillary acid protein. Cell viability was routinely monitored by trypan blue exclusion and was always Ͼ95%.
Isotope efflux measurements. Astrocytes grown on coverslips were incubated in an incubator in 5% CO 2 -95% air at 37°C overnight in 2.5 ml of MEM containing 10% heatinactivated horse serum plus 8 µCi/ml [ 3 H]taurine (final concentration of 270 nM). In some experiments, 16 µCi/ml Na 2 51 CrO 4 (final concentration of 230-270 nM) was also added to the incubation medium. The appearance of 51 Cr in the perfusate during release experiments can be used to monitor whether an increase in [ 3 H]taurine release is due to cell detachment or lysis (17) .
Before the start of efflux measurements, which were done at 35°C, the cells were preincubated for 10 min in HEPESbuffered solution at 35°C to remove extracellular isotope and serum-containing medium and adapt the cells to experimental conditions. The basal medium for efflux measurements consisted of (in mM) 122 NaCl, 3.3 KCl, 0.4 MgSO 4 , 1.3 CaCl 2 , 1.2 KH 2 PO 4 , 10 D-glucose, and 25 HEPES. NaOH (10 N) was used to adjust the pH to 7.4. After the washing procedure, the coverslips were inserted into a Lucite perfusion chamber with a depression precisely cut in the bottom to accommodate the 18 ϫ 18 ϫ 0.19-mm (width ϫ height ϫ thickness) glass coverslip. The chamber has a teflon screw top and when screwed down leaves a space above the cells of around 100 µm in height. The cells were perfused at a flow rate of 1.0 ml/min in an incubator set at 34.5-35°C with the basal HEPESbuffered medium (for composition, see above) or with high-K ϩ medium in which NaCl was replaced with an equimolar amount of KCl to give a final extracellular K ϩ concentration ([K ϩ ] o ) of 100 mM. The volume of the chamber above the coverslip is ϳ32 µl and allows a complete change of the perfusion buffer in Ͻ2 min, as directly determined by removal of a trypan blue-containing solution. The osmolarities of all buffers were measured by a freezing point osmometer (Advanced Instruments, Needham Heights, MA) and were in the range of 285-290 mosM. Fractions (1 min) were collected. At the end of experiment, the cells were removed from the coverslips with a solution containing 1% SDS plus 4 mM EDTA. When 51 Cr was present, the samples were first counted in a Clini-C LKB 1272 counter (Pharmacia, Gaitherburg, MD). Ecoscint (5 ml, National Diagnostics, Atlanta, GA) was then added, and each fraction was counted for 3 H in a Packard Tri-Carb 1900TR liquid scintillation analyzer (Packard Instrument, Meriden, CT) set at 2.0-18.6 keV to exclude 51 Cr radioactivity. Percent fractional release for each time point was calculated by dividing radioactivity released in each 1-min interval by the radioactivity left in the cells (the sum of all the radioactive counts in the remaining fractions up to the beginning of the fraction being measured, plus the radioactivity left in the cell digest) and multiplying by 100.
For measurement of hyposmotic-induced [ 3 H]taurine release, an identical experimental design was used. In hyposmotic medium, the concentration of NaCl was reduced by 50 mM (final osmolarity was 190 mosM).
Cell volume measurements. Astrocytic cell volume was measured at 35°C using an electric impedance method (33) , with minor modifications. The glass coverslips (no. 1.5; 0.19 Ϯ 0.01 mm thickness) plus cells were perfused at a constant rate of ϳ0.4-0.5 ml/min in the same Lucite chamber as used for the efflux experiments. Silver wire electrodes were inserted on both sides of the channel. These were soldered to an insulated copper wire and connected in series through a 1 M⍀ resistor to a lock-in amplifier (model SR510; Stanford Research Systems, Sunnyvale, CA) that supplied a 500-Hz, 5-V signal to the system. At this frequency, current does not pass through the cells. As the volume of the monolayer increases, the volume of the solution above the cells available for current flow decreases proportionally, resulting in an increase in the measured resistance. Because current is constant due to a 1-M⍀ series resistor, changes in voltage are directly proportional to changes in resistance of the solution above the monolayer and therefore directly related to the volume of solution above the cells. Because the resistivities of basal and high-K ϩ media were different, the resistivity of all experimental solutions was first measured in the chamber containing a blank coverslip, and all results were normalized in terms of medium resistivity. When different drugs were added to solutions, any effect on resistance was also checked but usually no effect was observed. To measure hyposmotic medium-induced volume regulation, 50 mM NaCl in isotonic medium was replaced with 100 mM D-mannitol to assure that Na ϩ concentration and medium resistivity would not differ between isotonic and hypotonic media (33) .
Calibrations and calculations, which were done in previous studies (33) , showed that a 1% change in resistance of the volume measurement chamber approximately correspond to a 20-25% change in total volume of the cell monolayer. Because we did not perform calibrations for the experiments presented in this study, all data are given as a normalized resistance signal.
[ (9) . Statistical analysis. Data are presented as means Ϯ SE of three to eight experiments performed on four different astro-cyte preparations. The difference between control and inhibitor-treated groups was analyzed by one-way classification ANOVA followed by comparison using Student's t-test. For multiple comparisons, Bonferonni's correction was applied.
RESULTS
Influence of high-K ϩ medium on cell volume, [ 3 H]taurine release, and [Ca 2ϩ ] i in primary astrocytic cultures.
Exposure of primary astrocytes to 100 mM KCl medium induced a progressively increasing cell swelling (Fig. 1A) . When high-K ϩ medium was replaced with basal medium, cell volume was restored to near initial levels within 5-7 min (Fig. 1A) . The high-K ϩ -induced cell swelling was accompanied by stimulation of [ 3 H]taurine release (Fig. 1B) . Successive exposures to high K ϩ medium led to an increase of labeled amino acid release, but each peak was somewhat smaller than the previous one. This made it problematic to quantitatively compare the actions of different drugs on taurine efflux in one experiment. Therefore, we measured both the average maximal fractional release during a 20-min exposure to high [K ϩ ] o , as observed at minute 20, and the sum of fractional releases (peak area) over a 20-min exposure to high [K ϩ ] o of the first peak of K ϩ -induced amino acid release, which was quite constant regarding both these parameters, under different conditions. Under control conditions, the mean maximal rate of release was 3.79 Ϯ 0.21%/min (n ϭ 8, mean Ϯ SE) and the average area of the peak over the entire 20-min exposure was 29.34 Ϯ 0.53% (n ϭ 8, mean Ϯ SE). The second and subsequent responses were more variable with regard to amplitude and area. Unlike [ 3 H]taurine, 51 Cr efflux, used for measuring cell loss or lysis (17) , was very low (0.03-0.08%/min) and rarely varied during the whole experimental period in basal and high-K ϩ conditions (Fig. 1B) .
We also monitored the influence of high K ϩ medium on [ (Fig. 1D, first response) . The subsequent high-K ϩ -induced cell swelling in extracellular Ca 2ϩ -free medium was somewhat slower but not significantly different compared with control high-K ϩ -induced cell swelling (Fig. 1D) .
If the cells were exposed to Ca 2ϩ -free medium 15 min before and during the first exposure to high [K ϩ ] o , the stimulated specific [ 3 H]taurine release, determined as the difference between total [ 3 H]taurine efflux and 51 Cr releases both being expressed in the same way as fractional isotope release (see MATERIALS AND METHODS), was inhibited by 20% compared with control high-[K ϩ ] oinduced responses (Table 1) . Also, the release was inhibited compared with the second exposure to high [K ϩ ] o in the same cell preparation (Fig. 1E ). As shown in Fig. 1E , exposure to Ca 2ϩ -free medium increased cell loss (or lysis) under basal conditions and in high-[K ϩ ] o medium, as evaluated by 51 Cr efflux. If Ca 2ϩ -free media were applied after the first or second exposure to high [K ϩ ] o , the increases in cell loss/lysis were much more pronounced (data not shown), probably mirroring lower stability of cell membranes or altered cell adhesion properties.
The replacement of basal medium with Ca 2ϩ -free buffer containing 50 µM EGTA (assuming that in nominally Ca 2ϩ -free medium Ca 2ϩ concentration is Յ1-2 µM, the calculated free [Ca 2ϩ ] o is Յ15 nM) decreased [Ca 2ϩ ] i to a new equilibrium level, which was 10-25 nM less compared with that in basal Ca 2ϩ -containing conditions (Fig. 1F) Values are means Ϯ SE; n ϭ no. of separate experiments (coverslips) involving 4 different culture preparations. Basal efflux rate (0.12 Ϯ 0.001%/min, mean Ϯ SE, n ϭ 50) or sum of effluxes within 20 min under basal conditions (2.38 Ϯ 0.04%, mean Ϯ SE, n ϭ 7) have been subtracted from maximal efflux rate and area of peak, respectively. Because of higher levels of basal release after treatment with fluphenazine (see Fig. 4C ), corresponding corrections were done for each experiment. (Fig. 1F ). This first response may be attributed to Ca 2ϩ release from intracellular stores due to extracellular Ca 2ϩ signal or volume changes (61) . After cells were returned to Ca 2ϩ -containing medium, [Ca 2ϩ ] i elevated to the starting level and the cells were subsequently able to respond to high K ϩ (Fig. 1F) .
Although (55) . To avoid any of the nonspecific alterations observed in Ca 2ϩ -free medium, all BAPTA experiments were done in the presence of 1 mM CaCl 2 . As shown in Fig. 1I, loading Fig. 1I .
Volume measurements showed that BAPTA-AM pretreatment failed to affect high-[K ϩ ] o -induced astrocytic swelling (Fig. 1G) . However, under basal conditions, loading with BAPTA-AM induced a fast and drastic volume increase followed by volume regulation with a time course similar to that previously observed in hyposmotic medium (33, 39, 40) .
The 30-min superfusion with 10 µM BAPTA-AM before application of high-[K ϩ ] o medium inhibited K ϩ -evoked [ 3 H]taurine release by 60-70% (Fig. 1H , Table  1 ). Loading with 3 µM BAPTA-AM (see Fig. 3B ) or with 4 µM fura 2-AM (Fig. 2 Cell volume measurements performed under similar conditions showed decreased hyposmotic swelling of the BAPTA-treated cells, whereas the rate of regulatory volume decrease (RVD) was not significantly changed (Fig. 3C , exposure to hyposmotic medium). Once again, under basal conditions, exposure of cells to 10 µM BAPTA-AM led to drastic transient increases in cell volume followed by an isosmotic volume restoration ( Fig. 3C and Fig. 1G , exposure to BAPTA-AM).
Influence of calmodulin antagonists on high-[K ϩ ] oand hyposmotic medium-induced [ 3 H]taurine release.
Because volume regulation in hyposmotic medium and the associated activation of K ϩ and anion fluxes are calmodulin-dependent processes in many cells (for review, see Ref. 26 (Fig. 4A and Table 1 ). The inhibition was concentration dependent, with an IC 50 of ϳ10 µM (Fig. 4B) . Long-term treatment, i.e., more than 30 min, with 25 µM trifluoperazine led to a progressive increase of cell loss evaluated as 51 Cr release and [ 3 H]taurine efflux, which was presumably due to cytotoxic effects of this drug (data not shown). At concentrations higher than 25 µM, increases of both basal and high-K ϩ -induced amino acid release (Fig. 4B ) and cell 51 Cr (data not shown) were observed even after short-term exposures (Յ20 min) to trifluoperazine. The irreversible calmodulin inhibitor fluphenazine (1) produced potent (over 80%) inhibition of swelling-induced [ 3 H]taurine efflux at a concentration of 25 µM (Fig. 4C, Table 1 ). As expected, its effect was completely irreversible (Fig. 4C) .
Under high-[K ϩ ] o conditions, the effect of calmodulin antagonists on taurine release may be due to specific inhibition of calmodulin-dependent volume signal transduction, direct interaction of the drugs with a volumedependent anion channel, or inhibition of KCl-induced cell swelling. To help distinguish these possibilities, we studied the influence of trifluoperazine on [ 3 H]taurine release under hyposmotic conditions. In this case, anticalmodulin agents appeared not to affect cell swelling due to water influx following the imposed osmotic gradient (2) but did block swelling-induced K ϩ release (3, 58) and cell volume regulation (2, 58) . The maximal fractional efflux rate of hyposmotic medium-induced [ 3 H]taurine release varied between different culture preparations. Therefore, we compared the influence of trifluoperazine on control values of efflux measured in the same cell preparation on the same day. Astrocytes were pretreated with different concentrations of trifluoperazine for 15-20 min and then subjected to an osmotic gradient of 100 mosM. Both maximal fractional release and area of peak were compared with control values. Trifluoperazine was a less effective blocker of volume-dependent amino acid release in hyposmotic medium compared with high-[K ϩ ] o conditions (Fig. 4, D  and E) . Also, in contrast to the identical effects of trifluoperazine on maximal rate and area of high-[K ϩ ] oinduced taurine release, we found that the area of the hyposmotic release is less sensitive to trifluoperazine pretreatment than the maximal fractional release: 15% vs. 40% inhibition for area and fractional release, respectively (Fig. 4E) . This discrepancy may be due to confounding effects of calmodulin antagonists on RVD (see DISCUSSION) .
To evaluate the possibility of whether the trifluoperazine effects were due to decreased cell swelling, we studied its influence on high-[K ϩ ] o -induced cell volume increase. Trifluoperazine at 25 µM inhibited K ϩ -evoked astrocytic swelling (Fig. 4F) . Unlike BAPTA-AM, it did not affect cell volume under basal isosmotic conditions.
DISCUSSION
It is well established that brain tissue swells in isosmotic high K ϩ medium (5, 6), which may be used as a model for cytotoxic (cellular) edema (16) . In pathophysiological conditions, such as ischemia, anoxia, or head injury, external K ϩ can rise to 80 mM (11, 48) . The main cell type contributing to brain cellular edema seems to be astroglial cells, which in vitro accumulate K ϩ both by Donnan uptake of KCl and through a diuretic-sensitive carrier mechanism (16, 59, 60) . In brain tissue as well as in cell cultures, K ϩ -evoked astrocytic swelling is slow and is not followed by cell volume regulation, presumably due to the inability of the cells to lose KCl in the face of high extracellular K ϩ (33, 44) . Several studies have shown mobilization of taurine under conditions that likely increase cell volume in brain (47, 57) . Swelling-induced release of taurine in pathophysiological conditions in vivo may be beneficial due to partial compensation for cell volume increases or diminution of the level of neuronal excitability, since taurine is an inhibitory neuromodulator (14). In the supraoptic nucleus, volume-dependent taurine efflux from glial cells was found to inhibit neuronal activity and was suggested to contribute to a neuroendocrine loop of body fluid homeostasis through the modulation of vasopressin release (7, 13) .
External Ca 2ϩ deprivation does not prevent high-K ϩ -induced taurine efflux but does affect glial cell volume and taurine release under basal conditions. In general, our findings confirm previous observations that high-K ϩ -induced release of The latter effect may be due to small inhibition of cell swelling, which was below the limit of statistical significance (see Fig. 1D ). However, as seen from our data, complications of experiments in which Ca 2ϩ -free medium is used include nonspecific alterations of plasma membrane permeability, cell lysis, or cell detachment as well as [Ca 2ϩ ] o -dependent cell volume changes. Such possibilities are not usually checked. We observed loss of radioactivity from astrocytes preloaded with 51 Cr in EGTA-containing Ca 2ϩ -free medium as well as in nominally Ca 2ϩ -free medium. These effects increased with time of superfusion, and, after [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] 51 Cr efflux evoked by Ca 2ϩ deprivation, possibly by making the membranes more stable by diminishing the transmembrane electric potential, as seen in phospholipid bilayers (52). The specific [ 3 H]taurine release (corrected for cell loss/lysis) was still significantly stimulated in basal Ca 2ϩ -free conditions. Measurements of cell volume revealed that deprivation of extracellular Ca 2ϩ induced fast and relatively long-lasting cell swelling, which also contributed to the [Ca 2ϩ ] o -dependent taurine release. Cell swelling under Ca 2ϩ -free conditions has previously been shown in a suspension of cultured astrocytes by Olson et al. (36) using a Coulter counter for cell volume monitoring. Nonspecific alterations of membrane permeability, cell loss/lysis, and/or volume changes induced by Ca 2ϩ -free medium may also explain some data in previous studies. A pronounced increase of basal taurine release in Ca 2ϩ -free EGTAcontaining medium has been shown in brain slices (34) , synaptosomes (46) , and cultured astrocytes (10, 43) .
The Ca 2ϩ channel blockers verapamil (50 µM) and Co 2ϩ (500 µM), known to suppress voltage-and volumedependent Ca 2ϩ channels (26, 27) Fig. 1G with Fig. 1I , it may be seen that loading with BAPTA-AM led to fast cell swelling within 2 min, whereas the average Ca 2ϩ concentration dropped below a presumed ''permissive'' level within 4-6 min. Why didn't we observe any immediate volume-dependent taurine release? The explanation may be that local [Ca 2ϩ ] i near the membrane is decreased faster than the average measurable [Ca 2ϩ ] i . In Ca 2ϩ -free medium (Fig. 1, D and E) or when lower Ca 2ϩ chelator concentrations were applied (Fig. 2) , isosmotic cell swelling did induce taurine release. An additional issue has been recently raised by Speake et al. (49) who showed that the lack of [Ca 2ϩ ] i elevation in lacrimal acinar cells loaded with fura 2 and exposed to hyposmotic medium is artifactual due to buffering of cytosolic Ca 2ϩ by fura 2. RVD in these cells was also suppressed when they were loaded with fura 2. We did not find any significant effect of loading with fura 2 on high-K ϩ -induced taurine release and cell volume changes in our preparation. (4, 31) . It is well established that calmodulin is involved in hyposmotic medium-induced RVD and electrolyte efflux in many cell types (21, 26) , including cultured astrocytes (2, 3, 58) . Because swelling under conditions of raised K ϩ differs from hyposmotic swelling with respect to both the rate and the magnitude of the volume changes, different ion transport and intracellular signaling mechanisms may be activated (50) . To our knowledge, no data exist on the involvement of calmodulin in high-[K ϩ ] o -induced astrocytic cell volume increase and associated amino acid fluxes. We found that the reversible calmodulin antagonist trifluoperazine potently and reversibly inhibited high-[K ϩ ] o -evoked taurine release. The IC 50 of ϳ10 µM for this inhibition was comparable to the K d of 5.8 µM for binding of trifluoperazine to calmodulin in vitro (25) . The irreversible calmodulin antagonist fluphenazine also produced irreversible effects in our system.
Is activation of volume-sensitive anion channel(s) or (K ϩ ϩ Cl Ϫ ) accumulation under high-K ϩ conditions the calmodulin-dependent step(s)? In the case of hyposmotic swelling, calmodulin antagonists did not affect astrocytic volume increase but did inhibit RVD (2, 58) . The inhibitory effect of trifluoperazine on the early rates of [ 3 H]taurine release in hyposmotic medium thus shows that the volume-dependent anion channel itself or volume signal transduction machinery is a likely target for calmodulin antagonists. However, if we calculated the effect of trifluoperazine on total area of the hyposmotic medium-induced [ 3 H]taurine release, it seemed less inhibited compared with the maximal fractional percent release (Fig. 4E) . This was in contrast to uniform effects of the drug on maximal release rate and area of high-[K ϩ ] o -induced release (Fig. 4E) . We explain this paradox by the effect of trifluoperazine on volume regulation. Prolonged hyposmotic cell swelling in the presence of trifluoperazine (2, 58) masks the inhibitory effect of the drug on the anion channel. As shown in Fig. 4D , 25 µM trifluoperazine clearly inhibited the initial hyposmotic [ 3 H]taurine release, whereas, at the 7th-10th min of exposure, we see a stimulation compared with control release. Thus the high sensitivity of the K ϩ -evoked [ 3 H]taurine release to calmodulin antagonists may involve two mechanisms, i.e., a direct effect on the anion channel or channel regulatory machinery and via suppression of high-[K ϩ ] o -induced cell swelling (Fig. 4F) (28) . It has been shown that loading of brain cells in vivo with Ca 2ϩ chelators strongly reduces ischemic brain injury, which was explained by prevention of excitotoxic neuronal death (55) . Some component of protection by chelators may be due to inhibition of excitatory amino acid (EAA) release from astrocytes (16) . It also seems that calmodulin inhibitors may be useful in the search for new pharmacological agents for treatment of ischemia and brain edema. Possible roles for their action include prevention of cytotoxic cell swelling and suppression of volume-dependent EAA release.
In (53) . However, high-[K ϩ ] o medium-and hyposmotic medium-induced amino acid release show quantitative differences in intracellular Ca 2ϩ sensitivity. This may be due to multiple anion transport pathways activated under hyposmotic conditions, as was established in a recent study (29) , some of which may be Ca 2ϩ insensitive or possesses low Ca 2ϩ sensitivity. In addition, high-[K ϩ ] oinduced astrocytic swelling is insensitive (or possesses low sensitivity) to alterations of extracellular and intracellular Ca 2ϩ concentration. Calmodulin inhibitors suppress both the hyposmotic medium-induced and to a larger extent the high-[K ϩ ] o -evoked [ 3 H]taurine release and also inhibit high-[K ϩ ] o -induced cell swelling. Therefore, the pronounced effects of calmodulin antagonists on the high-[K ϩ ] o -induced taurine release likely involve both a direct effect on the swelling-activated channel or channel regulatory machinery and an indirect action via inhibition of cell swelling.
